<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03087643</url>
  </required_header>
  <id_info>
    <org_study_id>241123</org_study_id>
    <nct_id>NCT03087643</nct_id>
  </id_info>
  <brief_title>Passive Mobilization and Vascular Function</brief_title>
  <official_title>Effectiveness of Passive Mobilization on Vascular Function of Bedridden Oldest Old</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universita di Verona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondazione Mons. Arrigo Mazzali - ONLUS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universita di Verona</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      With aging, vascular function (VF) declines. Inactivity and sedentary life style have been
      shown to contribute to the worsening of VF. Furthermore, bed rest, a condition commonly used
      for the management of many chronic conditions, has been proven to lead to even more
      deleterious consequences, including VF decline.

      This study evaluates the effect of passive mobilization of the lower limbs on VF in bedridden
      oldest-old. Half of the participants will undergo passive mobilization treatment in addition
      to standard therapies, while the other half will receive only standard therapies. We
      hypothesize that passive mobilization may improve nitric oxide (NO)-mediated endothelial
      function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Normally, cardiovascular function declines with age. Furthermore, cardiovascular function
      declines with immobility, promoting other adverse effects such as postural hypotension,
      impaired cardiac function, and thrombogenic events. Bed rest, a condition normally used in
      the management of many chronic pathologies in elderly people, leads to significant functional
      decline, reduction in physiologic reserve of most of the organ systems, including further
      cardiovascular decline. Fortunately, several studies have suggested interventions that may
      counteract immobility-induced cardiovascular dysfunction and ensure beneficial adaptations in
      the aging population. For example, passive mobilization of the limbs has been shown to
      improve cardiovascular function in bedridden oldest-old. However, the effect of passive
      mobilization on NO-mediated endothelial function have not been studied yet. Thus, the main
      aim of the study is to determine whether passive mobilization is an effective strategy to
      counteract endothelial dysfunction in bedridden oldest-old. For this purpose, bedridden
      individuals will be recruited and randomly assigned to two groups: one group will undergo
      passive mobilization treatment (PM) in addition to standard therapies, the other group (CTRL)
      will undergo standard therapies only. On the basis of preliminary data on a subgroup of ten
      participants, a sample of eighteen individuals will be allocated in each group so to reach a
      statistical power &gt;0.80 and an alpha &lt;0.05. The PM treatment will include knee
      flexion-extension and it will be performed for 30 minutes, 2 times a day, 5 days a week for 4
      weeks.

      Before, after the 4-week treatment, and 1 month after the end of the treatment NO-mediated
      endothelial function of all participants will be evaluated by means of flow-mediated dilation
      and passive limb movement tests.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2016</start_date>
  <completion_date type="Actual">October 6, 2017</completion_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Delta Peak Blood Flow During sPLM</measure>
    <time_frame>PRE and POST 4 weeks of treatment</time_frame>
    <description>Through the use of single Passive Limb Movement (sPLM) test, investigators assessed PLM-induced hyperemia [ delta peak; ml/min] in the common femoral artery of both, right and left legs, during and 60 second after a single passive knee flexion and extension lasting 1 second.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of % FMD</measure>
    <time_frame>PRE and POST 4 weeks of treatment</time_frame>
    <description>Through the use of Flow-mediated Dilation (FMD) test , investigators assessed the dilation capacity of right the brachial artery (%FMD) during two minutes following 5-minute ischemic occlusion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of Total Hemoglobin</measure>
    <time_frame>PRE and POST 4 weeks of treatment</time_frame>
    <description>Total hemoglobin [uM] in both, right and left vastus lateralis, was assessed by means of Near-infrared Spectroscopy [NIRS] during the sPLM test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Range of Motion</measure>
    <time_frame>PRE and POST 4 weeks of treatment</time_frame>
    <description>Assessment of the passive force/joint angle relationship during knee passive mobilization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Thickness of Vastus Lateralis</measure>
    <time_frame>PRE and POST 4 weeks of treatment</time_frame>
    <description>Evaluation of the architectural parameters (fascicle length, pinnation angle, and muscle thickness) of the vastus lateralis muscle by ultrasound</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Endothelial Dysfunction</condition>
  <condition>Aging</condition>
  <condition>Bed Rest</condition>
  <arm_group>
    <arm_group_label>Passive mobilization - PM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive 2 times a day, for 5 days a week 30 minutes of passive leg movement treatment including knee flexo-extension in addition to their standard therapies.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group - ctrl</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will receive ther standard therapies.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Passive mobilization - PM</intervention_name>
    <arm_group_label>Passive mobilization - PM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bedridden

        Exclusion Criteria:

          -  Neurodegenerative disease (i.e.Parkinson's disease, Alzheimer's disease)

          -  Heart failure

          -  Organ transplantation

          -  Liver failure

          -  Kidney failure

          -  Hemorrhage

          -  Neuromuscular diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>110 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mons. Mazzali Foundation</name>
      <address>
        <city>Mantua</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Milan</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Verona</name>
      <address>
        <city>Verona</city>
        <zip>37129</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Venturelli M, Amann M, Layec G, McDaniel J, Trinity JD, Fjeldstad AS, Ives SJ, Yonnet G, Richardson RS. Passive leg movement-induced hyperaemia with a spinal cord lesion: evidence of preserved vascular function. Acta Physiol (Oxf). 2014 Feb;210(2):429-39. doi: 10.1111/apha.12173. Epub 2013 Nov 5.</citation>
    <PMID>24119139</PMID>
  </reference>
  <reference>
    <citation>Groot HJ, Trinity JD, Layec G, Rossman MJ, Ives SJ, Richardson RS. Perfusion pressure and movement-induced hyperemia: evidence of limited vascular function and vasodilatory reserve with age. Am J Physiol Heart Circ Physiol. 2013 Feb 15;304(4):H610-9. doi: 10.1152/ajpheart.00656.2012. Epub 2012 Dec 21.</citation>
    <PMID>23262136</PMID>
  </reference>
  <reference>
    <citation>Trinity JD, Groot HJ, Layec G, Rossman MJ, Ives SJ, Morgan DE, Gmelch BS, Bledsoe A, Richardson RS. Passive leg movement and nitric oxide-mediated vascular function: the impact of age. Am J Physiol Heart Circ Physiol. 2015 Mar 15;308(6):H672-9. doi: 10.1152/ajpheart.00806.2014. Epub 2015 Jan 9.</citation>
    <PMID>25576629</PMID>
  </reference>
  <reference>
    <citation>Nelson AD, Rossman MJ, Witman MA, Barrett-O'Keefe Z, Groot HJ, Garten RS, Richardson RS. Nitric oxide-mediated vascular function in sepsis using passive leg movement as a novel assessment: a cross-sectional study. J Appl Physiol (1985). 2016 May 1;120(9):991-9. doi: 10.1152/japplphysiol.00961.2015. Epub 2016 Feb 11.</citation>
    <PMID>26869709</PMID>
  </reference>
  <reference>
    <citation>Venturelli M, Layec G, Trinity J, Hart CR, Broxterman RM, Richardson RS. Single passive leg movement-induced hyperemia: a simple vascular function assessment without a chronotropic response. J Appl Physiol (1985). 2017 Jan 1;122(1):28-37. doi: 10.1152/japplphysiol.00806.2016. Epub 2016 Nov 10.</citation>
    <PMID>27834672</PMID>
  </reference>
  <reference>
    <citation>Robine JM, Michel PJ. Looking forward to a general theory on population aging. Tijdschr Gerontol Geriatr. 2006 Sep;37(4):29-37.</citation>
    <PMID>17025012</PMID>
  </reference>
  <reference>
    <citation>Hadi HA, Carr CS, Al Suwaidi J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag. 2005;1(3):183-98. Review.</citation>
    <PMID>17319104</PMID>
  </reference>
  <reference>
    <citation>Ghiadoni L, Salvetti M, Muiesan ML, Taddei S. Evaluation of endothelial function by flow mediated dilation: methodological issues and clinical importance. High Blood Press Cardiovasc Prev. 2015 Mar;22(1):17-22. doi: 10.1007/s40292-014-0047-2. Epub 2014 Mar 12. Review.</citation>
    <PMID>24619864</PMID>
  </reference>
  <reference>
    <citation>Rousseau P. Immobility in the aged. Arch Fam Med. 1993 Feb;2(2):169-77; discussion 178. Review.</citation>
    <PMID>8275186</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>March 10, 2017</study_first_submitted>
  <study_first_submitted_qc>March 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2017</study_first_posted>
  <results_first_submitted>February 9, 2018</results_first_submitted>
  <results_first_submitted_qc>August 5, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 6, 2019</results_first_posted>
  <last_update_submitted>August 5, 2019</last_update_submitted>
  <last_update_submitted_qc>August 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universita di Verona</investigator_affiliation>
    <investigator_full_name>Massimo Venturelli, PhD</investigator_full_name>
    <investigator_title>Ph.D</investigator_title>
  </responsible_party>
  <keyword>Flow-mediated dilation</keyword>
  <keyword>Passive limb movement</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 14, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/43/NCT03087643/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Passive Mobilization - PM</title>
          <description>Participants will receive 2 times a day, for 5 days a week 30 minutes of passive leg movement treatment including knee flexo-extension in addition to their standard therapies.
Passive mobilization - PM</description>
        </group>
        <group group_id="P2">
          <title>Control Group - Ctrl</title>
          <description>Participants will receive ther standard therapies.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Passive Mobilization - PM</title>
          <description>Participants will receive 2 times a day, for 5 days a week 30 minutes of passive leg movement treatment including knee flexo-extension in addition to their standard therapies.
Passive mobilization - PM</description>
        </group>
        <group group_id="B2">
          <title>Control Group - Ctrl</title>
          <description>Participants will receive ther standard therapies.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="51"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="85" spread="8"/>
                    <measurement group_id="B2" value="87" spread="6"/>
                    <measurement group_id="B3" value="86" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Delta Peak Blood Flow during sPLM</title>
          <units>ml/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="113.7" spread="69.1"/>
                    <measurement group_id="B2" value="100.3" spread="70.4"/>
                    <measurement group_id="B3" value="104.5" spread="69.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>%Flow mediated dilation (FMD)</title>
          <units>%</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.6" spread="2.6"/>
                    <measurement group_id="B2" value="6.4" spread="2.0"/>
                    <measurement group_id="B3" value="7.3" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Range of Motion</title>
          <units>°</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.45" spread="33.37"/>
                    <measurement group_id="B2" value="41.24" spread="6.0"/>
                    <measurement group_id="B3" value="44.37" spread="24.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Muscle-Tendon Unit Stiffness</title>
          <units>N/°</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.86" spread="0.06"/>
                    <measurement group_id="B2" value="0.86" spread="0.06"/>
                    <measurement group_id="B3" value="0.86" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Muscle thickness Vastus Lateralis</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.78" spread="4.09"/>
                    <measurement group_id="B2" value="14.52" spread="3.69"/>
                    <measurement group_id="B3" value="14.59" spread="6.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total Hemoglobin (mmol/L)</title>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.2" spread="20.8"/>
                    <measurement group_id="B2" value="25.3" spread="12.9"/>
                    <measurement group_id="B3" value="29.8" spread="15.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change of Delta Peak Blood Flow During sPLM</title>
        <description>Through the use of single Passive Limb Movement (sPLM) test, investigators assessed PLM-induced hyperemia [ delta peak; ml/min] in the common femoral artery of both, right and left legs, during and 60 second after a single passive knee flexion and extension lasting 1 second.</description>
        <time_frame>PRE and POST 4 weeks of treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Passive Mobilization - PM</title>
            <description>Participants will receive 2 times a day, for 5 days a week 30 minutes of passive leg movement treatment including knee flexo-extension in addition to their standard therapies.
Passive mobilization - PM</description>
          </group>
          <group group_id="O2">
            <title>Control Group - Ctrl</title>
            <description>Participants will receive ther standard therapies.</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Delta Peak Blood Flow During sPLM</title>
          <description>Through the use of single Passive Limb Movement (sPLM) test, investigators assessed PLM-induced hyperemia [ delta peak; ml/min] in the common femoral artery of both, right and left legs, during and 60 second after a single passive knee flexion and extension lasting 1 second.</description>
          <units>ml/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.9" spread="30.7"/>
                    <measurement group_id="O2" value="-24.7" spread="27.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.0492</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change of % FMD</title>
        <description>Through the use of Flow-mediated Dilation (FMD) test , investigators assessed the dilation capacity of right the brachial artery (%FMD) during two minutes following 5-minute ischemic occlusion.</description>
        <time_frame>PRE and POST 4 weeks of treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Passive Mobilization - PM</title>
            <description>Participants will receive 2 times a day, for 5 days a week 30 minutes of passive leg movement treatment including knee flexo-extension in addition to their standard therapies.
Passive mobilization - PM</description>
          </group>
          <group group_id="O2">
            <title>Control Group - Ctrl</title>
            <description>Participants will receive ther standard therapies.</description>
          </group>
        </group_list>
        <measure>
          <title>Change of % FMD</title>
          <description>Through the use of Flow-mediated Dilation (FMD) test , investigators assessed the dilation capacity of right the brachial artery (%FMD) during two minutes following 5-minute ischemic occlusion.</description>
          <units>% of FMD</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="2.3"/>
                    <measurement group_id="O2" value="0.0" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.0283</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of Total Hemoglobin</title>
        <description>Total hemoglobin [uM] in both, right and left vastus lateralis, was assessed by means of Near-infrared Spectroscopy [NIRS] during the sPLM test.</description>
        <time_frame>PRE and POST 4 weeks of treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Passive Mobilization - PM</title>
            <description>Participants will receive 2 times a day, for 5 days a week 30 minutes of passive leg movement treatment including knee flexo-extension in addition to their standard therapies.
Passive mobilization - PM</description>
          </group>
          <group group_id="O2">
            <title>Control Group - Ctrl</title>
            <description>Participants will receive ther standard therapies.</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Total Hemoglobin</title>
          <description>Total hemoglobin [uM] in both, right and left vastus lateralis, was assessed by means of Near-infrared Spectroscopy [NIRS] during the sPLM test.</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-12.5" spread="8.6"/>
                    <measurement group_id="O2" value="-2.2" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.0321</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of Range of Motion</title>
        <description>Assessment of the passive force/joint angle relationship during knee passive mobilization</description>
        <time_frame>PRE and POST 4 weeks of treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Passive Mobilization - PM</title>
            <description>Participants will receive 2 times a day, for 5 days a week 30 minutes of passive leg movement treatment including knee flexo-extension in addition to their standard therapies.
Passive mobilization - PM</description>
          </group>
          <group group_id="O2">
            <title>Control Group - Ctrl</title>
            <description>Participants will receive ther standard therapies.</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Range of Motion</title>
          <description>Assessment of the passive force/joint angle relationship during knee passive mobilization</description>
          <units>°</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.13" spread="0.63"/>
                    <measurement group_id="O2" value="3.93" spread="0.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.0451</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of Thickness of Vastus Lateralis</title>
        <description>Evaluation of the architectural parameters (fascicle length, pinnation angle, and muscle thickness) of the vastus lateralis muscle by ultrasound</description>
        <time_frame>PRE and POST 4 weeks of treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Passive Mobilization - PM</title>
            <description>Participants will receive 2 times a day, for 5 days a week 30 minutes of passive leg movement treatment including knee flexo-extension in addition to their standard therapies.
Passive mobilization - PM</description>
          </group>
          <group group_id="O2">
            <title>Control Group - Ctrl</title>
            <description>Participants will receive ther standard therapies.</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Thickness of Vastus Lateralis</title>
          <description>Evaluation of the architectural parameters (fascicle length, pinnation angle, and muscle thickness) of the vastus lateralis muscle by ultrasound</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.53" spread="0.99"/>
                    <measurement group_id="O2" value="0.25" spread="0.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.0476</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Passive Mobilization - PM</title>
          <description>Participants will receive 2 times a day, for 5 days a week 30 minutes of passive leg movement treatment including knee flexo-extension in addition to their standard therapies.
Passive mobilization - PM</description>
        </group>
        <group group_id="E2">
          <title>Control Group - Ctrl</title>
          <description>Participants will receive ther standard therapies.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Massimo Venturelli</name_or_title>
      <organization>University of Verona</organization>
      <phone>00390458415114</phone>
      <email>massimo.venturelli@univr.it</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

